Stocks · News reference
Cellebrite Appoints Rogerio Rizzi as Executive Vice President of Corporate Strategy and Development
Cellebrite has appointed Rogerio Rizzi as its new Executive Vice President of Corporate Strategy and Development to lead the company's strategic growth initiatives.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Cellebrite Reports Third-Quarter 2026 Financial Results
Cellebrite reported Q3 2026 revenue of $149.0 million and adjusted EPS of $0.17, both exceeding analyst estimates.
Cellebrite Announces Autumn 2026 Product Release Featuring 'Genesis' AI Solution
Cellebrite has launched its Autumn 2026 product update, headlined by 'Genesis,' an agentic AI-powered tool designed to enhance digital investigative capabilities.
Digital Forensics Market Report 2026: Capitalize on the $14.85B-to-$31.74B Surge Through 2030 as Cloud, Mobile and Automated Investigations Disrupt Cisco, OpenText, Cellebrite, Nuix and Magnet Forensics
The global digital forensics market is projected to grow from $14.85 billion in 2025 to $31.74 billion by 2030, with a CAGR of 16.5%. Growth is driven by increasing cybercrime, cloud-based investigations, mobile device forensics, automation tools, and stricter data protection regulations. North America leads the market while Asia-Pacific is the fastest-growing region.
Twilio (TWLO) Surges 6.9%: Is This an Indication of Further Gains?
Twilio (TWLO) shares surged 6.9% to $284.53 following strong second-quarter results with 22% revenue growth to $1.5 billion and accelerating organic growth of 17%. The company raised its full-year 2026 organic revenue growth outlook to 13%-13.5%, driven by strength in messaging, voice, and software add-ons. However, with unchanged earnings estimate revisions over the past 30 days, analysts caution that the stock may struggle to sustain momentum without further positive estimate revisions.
Cellebrite Announces Board Authorized Corporate Reorganization To Redomicile In U.S. With New American Parent Company, Subject To Shareholder And Regulatory Approvals; Expects Completion By H1 2027